IOL CHEMICALS AND PHARMACEUTICALS
Quarterly Results Analysis [Sep2024]
IOL CHEMICALS AND PHARMACEUTICALS Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹526 Cr | ₹502 Cr | ₹504 Cr | ₹520 Cr | ₹545 Cr | ₹563 Cr | ₹587 Cr | ₹523 Cr |
Expenses | ₹484 Cr | ₹451 Cr | ₹454 Cr | ₹476 Cr | ₹481 Cr | ₹491 Cr | ₹492 Cr | ₹481 Cr |
Operating Income | ₹42 Cr | ₹51 Cr | ₹50 Cr | ₹44 Cr | ₹64 Cr | ₹73 Cr | ₹95 Cr | ₹43 Cr |
Other Income | ₹6 Cr | ₹7 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹9 Cr | ₹7 Cr |
Interest | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr |
Depreciation | ₹18 Cr | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹14 Cr | ₹12 Cr | ₹12 Cr |
Profit Before Tax | ₹26 Cr | ₹40 Cr | ₹37 Cr | ₹32 Cr | ₹51 Cr | ₹61 Cr | ₹87 Cr | ₹33 Cr |
Profit After Tax | ₹19 Cr | ₹30 Cr | ₹28 Cr | ₹23 Cr | ₹38 Cr | ₹46 Cr | ₹65 Cr | ₹24 Cr |
EPS | ₹3.26 | ₹5.10 | ₹4.70 | ₹3.93 | ₹6.45 | ₹7.81 | ₹11.03 | ₹4.05 |
Industry Peers & Returns | 1W | 1M | 1Y |
IOL CHEMICALS AND PHARMACEUTICALS | -2.5% | 13.2% | -12.2% |
SUN PHARMACEUTICAL INDUSTRIES | 2.9% | 6.4% | 48.1% |
CIPLA | 2.3% | 1% | 20.6% |
DR REDDYS LABORATORIES | 3.5% | 15.7% | 20.3% |
ZYDUS LIFESCIENCES | -0.1% | 2.3% | 41.1% |
DIVIS LABORATORIES | 0.5% | -2.1% | 59.2% |
MANKIND PHARMA | 2.5% | 12.4% | 50.8% |
TORRENT PHARMACEUTICALS | -0.8% | 5.7% | 54.3% |
LUPIN | 3.8% | 11.1% | 72.6% |
IOL CHEMICALS AND PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 4.65 % |
Y-o-Y | -3.59 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹526 Cr | 4.65 | |
Jun2024 | ₹502 Cr | -0.31 | |
Mar2024 | ₹504 Cr | -3.16 | |
Dec2023 | ₹520 Cr | -4.57 | |
Sep2023 | ₹545 Cr | -3.17 | |
Jun2023 | ₹563 Cr | -4.09 | |
Mar2023 | ₹587 Cr | 12.17 | |
Dec2022 | ₹523 Cr | - |
IOL CHEMICALS AND PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -18.67 % |
Y-o-Y | -35.25 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹42 Cr | -18.67 | |
Jun2024 | ₹51 Cr | 3.21 | |
Mar2024 | ₹50 Cr | 11.66 | |
Dec2023 | ₹44 Cr | -30.92 | |
Sep2023 | ₹64 Cr | -11.47 | |
Jun2023 | ₹73 Cr | -23.90 | |
Mar2023 | ₹95 Cr | 123.29 | |
Dec2022 | ₹43 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -22.22 % |
Y-o-Y | -32.80 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 7.91% | -22.22 | |
Jun2024 | 10.17% | 3.46 | |
Mar2024 | 9.83% | 15.38 | |
Dec2023 | 8.52% | -27.61 | |
Sep2023 | 11.77% | -8.62 | |
Jun2023 | 12.88% | -20.64 | |
Mar2023 | 16.23% | 99.14 | |
Dec2022 | 8.15% | - |
IOL CHEMICALS AND PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -36.10 % |
Y-o-Y | -49.43 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹19 Cr | -36.10 | |
Jun2024 | ₹30 Cr | 8.51 | |
Mar2024 | ₹28 Cr | 19.67 | |
Dec2023 | ₹23 Cr | -39.05 | |
Sep2023 | ₹38 Cr | -17.42 | |
Jun2023 | ₹46 Cr | -29.21 | |
Mar2023 | ₹65 Cr | 172.41 | |
Dec2022 | ₹24 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -39.03 % |
Y-o-Y | -47.55 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 3.64 % | -39.03 | |
Jun2024 | 5.97 % | 8.94 | |
Mar2024 | 5.48 % | 23.42 | |
Dec2023 | 4.44 % | -36.02 | |
Sep2023 | 6.94 % | -14.74 | |
Jun2023 | 8.14 % | -26.20 | |
Mar2023 | 11.03 % | 142.95 | |
Dec2022 | 4.54 % | - |
IOL CHEMICALS AND PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -36.08 % |
Y-o-Y | -49.46 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹3.26 | -36.08 | |
Jun2024 | ₹5.1 | 8.51 | |
Mar2024 | ₹4.7 | 19.59 | |
Dec2023 | ₹3.93 | -39.07 | |
Sep2023 | ₹6.45 | -17.41 | |
Jun2023 | ₹7.81 | -29.19 | |
Mar2023 | ₹11.03 | 172.35 | |
Dec2022 | ₹4.05 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD